首页> 外国专利> SPECIFICALLY ACTIVATED MICROMOLECULAR TARGET COUPLING BODY IN TUMOR MICROENVIRONMENT AND USE THEREOF

SPECIFICALLY ACTIVATED MICROMOLECULAR TARGET COUPLING BODY IN TUMOR MICROENVIRONMENT AND USE THEREOF

机译:肿瘤微环境中特定活化的微靶标结合体及其用途

摘要

Provided are an anticancer compound comprising a cleavable linker specifically activated in a tumor microenvironment, and use thereof. The anticancer compound is represented by the following formula, wherein, R1 is a normal functional group or a protection group; R2 is Ala, Thr, Val or Ile; R3 is Ala, Val or Asn; R4 is a drug group linked via a hydroxyl group or an amino group; and the general formula of the drug is R4H. The anticancer compound is only activated at a local portion of a tumor, thus avoiding the defect of immune system damage of a traditional chemotherapeutic drug, and promoting tumor immunization by removing a tumor immunosuppression cell. The anticancer compound or pharmaceutical composition thereof is jointly used with immunotherapy, thus improving the effect of treating the tumor, and effectively inhibiting tumor metastasis and osseous metastasis.
机译:提供了包含在肿瘤微环境中特异性活化的可裂解的接头的抗癌化合物及其用途。该抗癌化合物由下式表示:其中,R 1 为正官能团或保护基。 R 2 是Ala,Thr,Val或Ile; R 3 是Ala,Val或Asn; R 4 是通过羟基或氨基连接的药物基团;该药物的通式为R 4 H。该抗癌化合物仅在肿瘤的局部部分被激活,从而避免了传统化学治疗药物的免疫系统损害的缺陷,并通过去除肿瘤免疫抑制细胞来促进肿瘤免疫。本发明的抗癌化合物或其药物组合物可与免疫疗法联合使用,从而提高了治疗肿瘤的效果,并有效地抑制了肿瘤的转移和骨转移。 <图像文件=“ IMGA0001.GIF” he =“ 21” imgContent =“ chem” imgFormat =“ GIF” wi =“ 79” />

著录项

  • 公开/公告号EP3184540A1

    专利类型

  • 公开/公告日2017-06-28

    原文格式PDF

  • 申请/专利号EP20150833275

  • 发明设计人 LIU CHEN;LIU YUAN;

    申请日2015-08-21

  • 分类号C07K5/083;A61K31/4745;A61K31/7068;A61K31/337;A61P35;A61P27/02;A61P27/06;

  • 国家 EP

  • 入库时间 2022-08-21 14:03:12

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号